Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma

Luis F. PorrataDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USACorrespondence[email protected]

Kay M. RistowDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

Thomas M. HabermannDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

Thomas E. WitzigDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

Joseph P. ColganDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

David J. InwardsDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

Stephen M. AnsellDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

Ivana N. MicallefDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

Patrick B. JohnstonDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

Grzegorz NowakowskiDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

Carrie A. ThompsonDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

Svetomir N. MarkovicDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA

Your download is now in progress and you may close this window